P‐glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells

The Prostate
2004.0

Abstract

P-glycoprotein (P-gp) is commonly associated with multi-drug resistance (MDR) in cancer cells and the efflux of a broad spectrum of chemicals from the cell, including many chemotherapeutics and certain steroid hormones. The impact of P-gp and mechanisms involved in androgen transport and cellular accumulation within normal and malignant prostate cells remains unclear.Following incubation of LNCaP, PC-3, HeLa, and HeLa FLAG-androgen receptor (AR) cells with (3)H-dihydrotestosterone (DHT) alone and in combination with P-gp inhibitors, PSC-833 and verapamil, we examined the cellular accumulation and efflux of androgens, as well as gene transcriptional response.Our data reveal that the cellular transport and accumulation of DHT is dependent on the expression of functional AR and modulated by P-gp. P-gp over-expression by both transient transfection and aspirin treatment in LNCaP cells showed decreased intracellular DHT accumulation, further suggesting DHT efflux is P-gp regulated.Androgen responsiveness may be modulated by P-gp in prostate cancer cells. The biological consequences of increased P-gp expression are decreased androgen accumulation and a corresponding decrease in androgen-regulated transcriptional activity and PSA gene expression.

Knowledge Graph

Similar Paper

P‐glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells
The Prostate 2004.0
Influence of Different Chemicals on MDR-1 P-Glycoprotein Expression and Activity in the HK-2 Proximal Tubular Cell Line
Toxicology and Applied Pharmacology 2002.0
Up‐Regulation of P‐Glycoprotein Expression in Rat Liver Cells by Acute Doxorubicin Treatment
European Journal of Biochemistry 1997.0
Modulation of the Cellular Accumulation and Intracellular Activity of Daptomycin towards Phagocytized Staphylococcus aureus by the P-Glycoprotein (MDR1) Efflux Transporter in Human THP-1 Macrophages and Madin-Darby Canine Kidney Cells
Antimicrobial Agents and Chemotherapy 2007.0
The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P‐glycoprotein function
FEBS Letters 1994.0
P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment
Biochemical Pharmacology 1996.0
Multidrug Resistance Protein (MRP) 1 and MRP3 Attenuate Cytotoxic and Transactivating Effects of the Cyclopentenone Prostaglandin, 15-Deoxy-Δ<sup>12,14</sup>Prostaglandin J<sub>2</sub> in MCF7 Breast Cancer Cells
Biochemistry 2003.0
Multidrug resistance gene expression in rodents and rodent hepatocytes treated with mitoxantrone
Biochemical Pharmacology 1996.0
Functional characterization of the rat mdr1b encoded P-glycoprotein: not all inducing agents are substrates
Carcinogenesis 1997.0
HumanMDR1and Mousemdr1aP-Glycoprotein Alter the Cellular Retention and Disposition of Erythromycin, but Not of Retinoic Acid or Benzo(a)pyrene
Archives of Biochemistry and Biophysics 1998.0